Last reviewed · How we verify
NCT06801951: HMB exercise
Oral Supplement and Acute Resistance Exercise
NA trial testing acute resistance exercise with oral nutrition supplementation in Chronic Obstructive Pulmonary Disease in 16 participants. Completed in 27 February 2020.
27 February 2020
Quick facts
| Lead sponsor | Texas A&M University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 16 |
| Start date | 11 December 2017 |
| Primary completion | 27 February 2020 |
| Estimated completion | 27 February 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- acute resistance exercise with oral nutrition supplementation
- stable tracer infusion
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Sponsor
Texas A&M University
Who can join
Adults 45 to 100, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study should provide the mechanistic basis for and evaluation of a new nutritional formulation to be used alongside exercise training to improve muscle function and exercise performance by minimizing exercise induced metabolic deregulation in patients with Chronic Obstructive Pulmonary Disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Whole-body and intracellular arginine metabolism in hypertension: role of disease severity and sex.
Hüttl VN, Deutz N, Wierzchowska-McNew RA, Ruebush LE, et al · · 2026 · PMID 42149813 · DOI 10.1093/ajh/hpag047
Verify or expand the search:
- PubMed search for NCT06801951
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other Texas A&M University trials
Trials by the same sponsor.
- NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
- NCT06950775 — The Neighborhood & Health Study · recruiting
- NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
- NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
- NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06801951 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
- Last refreshed: 30 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06801951.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing